Robert Repella, Executive Vice-President and General Manager of Wyeth BioPharma, made his visit to Seoul between September 22 and 23.
During his two-day visit, Repella had an opportunity to introduce the company's R&D and investment plan, as well as discuss the development of new biopharmaceuticals with Korean health experts.
Wyeth Pharmaceuticals plans to launch a series of new biopharm...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.